TGF-β and cancer

被引:353
|
作者
Bierie, B
Moses, HL
机构
[1] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA
关键词
TGF-beta; Smad; cancer; stroma; epithelium; interactions; cross-talk;
D O I
10.1016/j.cytogfr.2005.09.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TGF-beta signaling regulates tumorigenesis and ill human cancer its signaling pathways are often modified during tumor progression. Prior to initiation and early during progression TGF-beta acts upon the epithelium as a tumor Suppressor, however at later stages it is often a tumor promoter. Over the years, many studies have focused on the epithelial cell autonomous role for TGF-beta, however, TGF-beta is not strictly limited to this compartment in vivo. Recent studies addressing TGF-beta mediated stromal-epithelial interactions have significantly improved our understanding related to the regulation of cancer. In addition, stromal fibroblast cell autonomous effects have been observed in response to TGF-beta stimulation. According to the current literature and experimental evidence, TGF-beta is a potent ligand that regulates carcinoma initiation, progression and metastasis through a broad and complex spectrum of interdependent interactions. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:29 / 40
页数:12
相关论文
共 50 条
  • [41] Chronic liver injury, TGF-β, and cancer
    Bissell, DM
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04) : 179 - 190
  • [42] TrkC binds to the type II TGF-β receptor to suppress TGF-β signaling
    Jin, W.
    Yun, C.
    Kwak, M-K
    Kim, T-A
    Kim, S-J
    ONCOGENE, 2007, 26 (55) : 7684 - 7691
  • [43] Defective TGF-β signaling sensitizes human cancer cells to rapamycin
    Gadir, N.
    Jackson, D. N.
    Lee, E.
    Foster, D. A.
    ONCOGENE, 2008, 27 (08) : 1055 - 1062
  • [44] Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatment
    Perrot, Carole Y.
    Javelaud, Delphine
    Mauviel, Alain
    PHARMACOLOGY & THERAPEUTICS, 2013, 137 (02) : 183 - 199
  • [45] Down regulation of TGF-β receptors in human colorectal cancer:: implications for cancer development
    Matsushita, M
    Matsuzaki, K
    Date, M
    Watanabe, T
    Shibano, K
    Nakagawa, T
    Yanagitani, S
    Amoh, Y
    Takemoto, H
    Ogata, N
    Yamamoto, C
    Kubota, Y
    Seki, F
    Inokuchi, H
    Nishizawa, M
    Takada, H
    Sawamura, T
    Okamura, A
    Inoue, K
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 194 - 205
  • [46] Angiotensin Inhibition, TGF-β and EMT in Cancer
    Pallasch, Fabian Bernhard
    Schumacher, Udo
    CANCERS, 2020, 12 (10) : 1 - 22
  • [47] Alterations in components of the TGF-β superfamily signaling pathways in human cancer
    Levy, L
    Hill, CS
    CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) : 41 - 58
  • [48] TGF-β signaling and epithelial-mesenchymal transition in cancer progression
    Katsuno, Yoko
    Lamouille, Samy
    Derynck, Rik
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 76 - 84
  • [49] TGF-β and cancer:: Is Smad3 a repressor of hTERT gene?
    Li, H
    Xu, DK
    Toh, BH
    Liu, JP
    CELL RESEARCH, 2006, 16 (02) : 169 - 173
  • [50] The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer
    Lopa Mishra
    Kirti Shetty
    Yi Tang
    August Stuart
    Stephen W Byers
    Oncogene, 2005, 24 : 5775 - 5789